China is a significant part of the Firm’s international practice. The Firm’s China Practice Group represents U.S. companies with operations and activities in China, as well as Chinese enterprises that are listed or do business in the U.S. Our China Practice has experience in a wide range of China-related matters, and we assist these businesses with strategic growth options, such as private equity financing, mergers and acquisitions, and public offerings. We have frequent and regular involvement in China-related transactions, including Reverse Mergers, Alternative Public Offerings, Private Placements, PIPEs, SPACs, IPOs, and Going Private Transactions. We also have extensive connections to the investment banks, hedge funds, private equity, and venture capital that are actively engaged in transactions related to China. We are fluent in Mandarin, Cantonese and English, and we are able to prepare documentation in these languages and liaise with local PRC counsels to address related issues and concerns. Our attorneys regularly visit all regions of China.